Expert Panel Backs a Drug to Increase Women’s Sex Drive
Government advisers Thursday recommended approval of what would be the first drug to treat lack of sexual desire in women.
The advisory committee to the Food and Drug Administration voted 18 to 6 that the drug, flibanserin, be approved. All of those who voted yes said approval should come only if certain measures are taken to reduce the risks of side effects.
Flibanserin, a pink pill that would be taken every day at bedtime, would be approved to treat lack of sexual desire in premenopausal women that cannot be attributed to disease or other known causes. Sprout Pharmaceuticals, which owns flibanserin, said that 7 percent of premenopausal women had this condition, known as hypoactive sexual desire disorder.
READ MORE »
http://www.nytimes.com/2015/06/05/business/panel-backs-a-drug-to-increase-womens-sex-drive.html?emc=edit_na_20150604